Nifty Future R1: 7839 R2: 7893 R3: 7927
Pivot: 7804 S1: 7750 S2: 7716 S3: 7663
Chart Interpretation :-
Nifty spot close below at 7800 on Tuesday nifty spot may be consolidate between the level of 7720-7820.above the level of 7850 fresh buying may be seen in nifty .
Mechanical indicator stochastic and RSI also showing buying movement in nifty future.
Index Outlook :-
NIFTY FUTURE:-
Nifty closed in red on Tuesday on the back of selling in front line blue chip counters. Sensex closed 145.25 points down at 25,590.65, while NSE Nifty settled 48.35 points down at 7,786.10.
INTRADAY STRATIGY:-
Buy Nifty above the range of 7840 for target of 7880-7950 stop loss: 7750.
Corporate news :-
HDIL registered a development agreement with DK Realty (India) to sell the development rights in respect of the piece and parcel of land situated at Kurla, Mumbai.
Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Olopatadine hydrochloride ophthalmic solution.
Glenmark Pharmaceuticals has received the final nod from the US health regulator for a generic version of anti- bacterial drug Zyvox.
If you want to more information regarding the Nifty spot, Equity tips & many other call @ 8109999233 or fill form http://equityresearchlab.com/Freetrial.php
Pivot: 7804 S1: 7750 S2: 7716 S3: 7663
Chart Interpretation :-
Nifty spot close below at 7800 on Tuesday nifty spot may be consolidate between the level of 7720-7820.above the level of 7850 fresh buying may be seen in nifty .
Mechanical indicator stochastic and RSI also showing buying movement in nifty future.
Index Outlook :-
NIFTY FUTURE:-
Nifty closed in red on Tuesday on the back of selling in front line blue chip counters. Sensex closed 145.25 points down at 25,590.65, while NSE Nifty settled 48.35 points down at 7,786.10.
INTRADAY STRATIGY:-
Buy Nifty above the range of 7840 for target of 7880-7950 stop loss: 7750.
HDIL registered a development agreement with DK Realty (India) to sell the development rights in respect of the piece and parcel of land situated at Kurla, Mumbai.
Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Olopatadine hydrochloride ophthalmic solution.
Glenmark Pharmaceuticals has received the final nod from the US health regulator for a generic version of anti- bacterial drug Zyvox.
If you want to more information regarding the Nifty spot, Equity tips & many other call @ 8109999233 or fill form http://equityresearchlab.com/Freetrial.php
Have lost money in Stock Market, don't panic just consult Epic Research to get daily free Commodity tips to recover it fast.
ReplyDelete